Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
- Acronyms FAITH
- 02 Dec 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
- 02 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
- 19 May 2016 Status changed from recruiting to active, no longer recruiting.